Polycaprolactone versus calcium hydroxylapatite injectable treatments in the T-zone for facial rejuvenation: a clinical comparative study.

Gao C, Wang X

Open source

DOI
10.62347/oosp9576
Published
2026
Container
American journal of translational research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.62347/oosp9576,
  title = {Polycaprolactone versus calcium hydroxylapatite injectable treatments in the T-zone for facial rejuvenation: a clinical comparative study.},
  author = {Gao C and Wang X},
  year = {2026},
  journal = {American journal of translational research},
  doi = {10.62347/oosp9576},
  url = {https://doi.org/10.62347/oosp9576}
}

RIS

TY  - JOUR
TI  - Polycaprolactone versus calcium hydroxylapatite injectable treatments in the T-zone for facial rejuvenation: a clinical comparative study.
AU  - Gao C
AU  - Wang X
PY  - 2026
JO  - American journal of translational research
DO  - 10.62347/oosp9576
UR  - https://doi.org/10.62347/oosp9576
ER  - 

APA

C, G., & X, W. (2026). Polycaprolactone versus calcium hydroxylapatite injectable treatments in the T-zone for facial rejuvenation: a clinical comparative study.. American journal of translational research. https://doi.org/10.62347/oosp9576

Source records